menu
    • menu

    Company profile for 4D Pharma

    NEW Drugs in Dev: 5
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics. Founded on over two decades of research, the Company was formed in 2014 and listed on the UK stock market. From the outset, we constructed a library of bacteria isolated from healthy human samples, which now stands at more than 8,000 strains. We have built a drug discovery platform, known as MicroRx, which has show...
    We are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics. Founded on over two decades of research, the Company was formed in 2014 and listed on the UK stock market. From the outset, we constructed a library of bacteria isolated from healthy human samples, which now stands at more than 8,000 strains. We have built a drug discovery platform, known as MicroRx, which has shown the ability to rapidly identify bacteria from our library that have therapeutically relevant effects. To date, the Company has initiated 13 live biotherapeutic programmes across a broad range of diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    4D Pharmaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    9 Bond Court, Leeds, LS1 2JZ
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.4dpharmaplc.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/4d-pharma-plc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq
    4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq

    28 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220628006046/en

    BUSINESSWIRE
    28 Jun 2022
    Share Share
    4D pharma Presents Trial on Study of MRx0518 in Combination with BAVENCIO
    4D pharma Presents Trial on Study of MRx0518 in Combination with BAVENCIO

    26 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220526005734/en

    BUSINESSWIRE
    26 May 2022
    Share Share
    4D pharma to Present at the H.C. Wainwright Global Investment Conference
    4D pharma to Present at the H.C. Wainwright Global Investment Conference

    19 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220519005720/en

    BUSINESSWIRE
    19 May 2022
    Share Share
    4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004
    4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004

    17 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220517005293/en

    BUSINESSWIRE
    17 May 2022
    Share Share
    4D pharma Reports Full Year 2021 Financial Results
    4D pharma Reports Full Year 2021 Financial Results

    31 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220331006021/en

    BUSINESSWIRE
    31 Mar 2022
    Share Share
    Despite 0% response rate, 4D hits primary goal in cancer trial
    Despite 0% response rate, 4D hits primary goal in cancer trial

    24 Mar 2022

    // N.P. Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/despite-0-response-rate-4d-hits-primary-endpoint-keytruda-combo-trial-sending-stock-skyward

    N.P. Taylor FIERCEBIOTECH
    24 Mar 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search